BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22686318)

  • 1. N-Acetyltransferase 2 and glutathione s-transferase M1 in colon and rectal cancer cases from an industrialized area.
    Golka K; Roemer HC; Weistenhöfer W; Blaszkewicz M; Hammad S; Reckwitz T; Loehlein D; Hartel M; Hengstler JG; Geller F
    J Toxicol Environ Health A; 2012; 75(8-10):572-81. PubMed ID: 22686318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyltransferase 1 in colon and rectal cancer cases from an industrialized area.
    Roemer HC; Weistenhofer W; Lohlein D; Geller F; Blomeke B; Golka K
    J Toxicol Environ Health A; 2008; 71(13-14):902-5. PubMed ID: 18569593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
    Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer.
    Slattery ML; Potter JD; Samowitz W; Bigler J; Caan B; Leppert M
    Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1079-84. PubMed ID: 9865425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study.
    Zupa A; Sgambato A; Bianchino G; Improta G; Grieco V; LA Torre G; Campisi B; Traficante A; Aieta M; Cittadini A
    Anticancer Res; 2009 May; 29(5):1709-14. PubMed ID: 19443391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study].
    Chen K; Jiang QT; Ma XY; Yao KY; Leng SG; Yu WP; Zhou HG
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):645-8. PubMed ID: 15777499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
    Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.
    Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA
    Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer.
    Slattery ML; Edwards S; Curtin K; Schaffer D; Neuhausen S
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):882-9. PubMed ID: 14504199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea.
    Kim DH; Ahn YO; Lee BH; Tsuji E; Kiyohara C; Kono S
    Cancer Lett; 2004 Dec; 216(2):199-205. PubMed ID: 15533596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetyl transferase 2/environmental factors and their association as a modulating risk factor for sporadic colon and rectal cancer.
    Procopciuc LM; Osian G; Iancu M
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27883249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
    Kim WJ; Lee HL; Lee SC; Kim YT; Kim H
    J Urol; 2000 Jul; 164(1):209-13. PubMed ID: 10840461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: a case-control study in an Indian population.
    Wang J; Jiang J; Zhao Y; Gajalakshmi V; Kuriki K; Suzuki S; Nagaya T; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
    Cancer Epidemiol; 2011 Feb; 35(1):66-72. PubMed ID: 20688591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J; Cascorbi I; Kerb R; Roots I
    Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.